Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Inflammatory Bowel Diseases

  Free Subscription


1 Aliment Pharmacol Ther
1 BMC Gastroenterol
2 Clin Gastroenterol Hepatol
2 Clin Res Hepatol Gastroenterol
3 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
5 Inflamm Bowel Dis
1 J Clin Gastroenterol
2 Lancet

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aliment Pharmacol Ther

  1. SWAMINATHAN A, Fan D, Borichevsky GM, Mules TC, et al
    The disease severity index for inflammatory bowel disease is associated with psychological symptoms, quality of life and predicts a more complicated disease course.
    Aliment Pharmacol Ther. 2022 May 27. doi: 10.1111/apt.17058.
    PubMed         Abstract available

    BMC Gastroenterol

  2. SASSAKI LY, Magro DO, Saad-Hossne R, Baima JP, et al
    Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB).
    BMC Gastroenterol. 2022;22:268.
    PubMed         Abstract available

    Clin Gastroenterol Hepatol

  3. OZEKI K, Tanida S, Kataoka H
    Aseptic abscess syndrome with ulcerative colitis and pyoderma gangrenosum.
    Clin Gastroenterol Hepatol. 2022 May 25. pii: S1542-3565(22)00512.

  4. STRAATMIJER T, Biemans VB, Visschedijk M, Hoentjen F, et al
    Superior effectiveness of tofacitinib compared to vedolizumab in anti-TNF experienced ulcerative colitis patients: a nationwide Dutch Registry study.
    Clin Gastroenterol Hepatol. 2022 May 26. pii: S1542-3565(22)00510.
    PubMed         Abstract available

    Clin Res Hepatol Gastroenterol

  5. YZET C, Brazier F, Sebbagh V, Vanelslander P, et al
    Complete endoscopic healing is associated with lower disability than partial endoscopic healing in Crohn's disease: A prospective multicenter study.
    Clin Res Hepatol Gastroenterol. 2022;46:101887.
    PubMed         Abstract available

  6. HE C, Li H, Zhou P, Zhang W, et al
    A novel XIAP mutation in an adult Chinese patient with refractory Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101845.

    Dig Dis Sci

  7. GEORGOPOULOS I, Mavrigiannaki E, Stasinopoulou S, Renieris G, et al
    Experimental Intestinal Stenosis Alters Crohn's Disease-Like Intestinal Inflammation in Ileitis-Prone Mice.
    Dig Dis Sci. 2022;67:1783-1793.
    PubMed         Abstract available

  8. KUMAR A, Shenoy V, Buckley MC, Durbin L, et al
    Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.
    Dig Dis Sci. 2022 May 27. pii: 10.1007/s10620-022-07530.
    PubMed         Abstract available

  9. ZHANG M, Xie Z, Zhou G, Wang Y, et al
    Conflicting Effects of Wnt-5a in Ulcerative Colitis: You Wnt Some, You Lose Some.
    Dig Dis Sci. 2022 May 31. pii: 10.1007/s10620-022-07542.

    Eur J Gastroenterol Hepatol

  10. GIRI S, Ingawale S
    Use of restrictive iron transfusion strategy in inflammatory bowel disease: one size does not fit all.
    Eur J Gastroenterol Hepatol. 2022;34:807.

    Gastroenterol Hepatol

  11. LATRAS CORTES I, Sierra-Ausin M
    Tacrolimus plus ustekinumab in refractory ulcerative colitis.
    Gastroenterol Hepatol. 2022 May 13. pii: S0210-5705(22)00145.

    Inflamm Bowel Dis

  12. WINTHROP KL, Vermeire S, Long MD, Panes J, et al
    Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
    Inflamm Bowel Dis. 2022 Jun 1. pii: 6596831. doi: 10.1093.
    PubMed         Abstract available

  13. TSE CS, Melmed GY, Siegel CA, Weng CH, et al
    Bidirectional Correlations Between Health Confidence and Inflammatory Bowel Disease Activity: A Nationwide Longitudinal Cohort Study.
    Inflamm Bowel Dis. 2022 May 28. pii: 6594471. doi: 10.1093.

  14. WINTER RW, Boyd T, Chan WW, Levy AN, et al
    Risk Factors for Voluntary Childlessness in Men and Women With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 May 28. pii: 6594473. doi: 10.1093.

  15. WU S, Xie S, Yuan C, Yang Z, et al
    Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank.
    Inflamm Bowel Dis. 2022 May 27. pii: 6594105. doi: 10.1093.
    PubMed         Abstract available

  16. SOOKAROMDEE P, Wiwanitkit V
    Correspondence on "Immunogenicity of COVID-19 Vaccine Doses in Patients With Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2022 May 27. pii: 6594100. doi: 10.1093.

    J Clin Gastroenterol

  17. TRIVEDI HD, Lopes EW, Glissen Brown J, Dudani S, et al
    Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
    J Clin Gastroenterol. 2022 Jun 1. pii: 00004836-990000000-00030.
    PubMed         Abstract available


  18. DANESE S, Vermeire S, Zhou W, Pangan AL, et al
    Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.
    Lancet. 2022 May 26. pii: S0140-6736(22)00581.
    PubMed         Abstract available

    Upadacitinib for ulcerative colitis.
    Lancet. 2022 May 26. pii: S0140-6736(22)00778.

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.